asthma
heterogen
disord
interact
genet
predisposit
atopi
environment
factor
includ
environment
allergen
air
pollut
respiratori
infect
current
definit
asthma
combin
presenc
chronic
inflammatori
airway
hyperrespons
episod
airway
obstruct
variabl
degre
revers
treatment
spontan
asthma
worldwid
pandem
level
past
year
million
peopl
afflict
global
although
asthma
consid
common
affluent
develop
countri
approxim
half
develop
countri
account
twothird
world
popul
estim
asthma
account
annual
death
number
asthmat
increas
million
new
case
unit
state
popul
asthma
substanti
annual
morbid
hospit
million
emerg
visit
annual
cost
billion
hallmark
asthma
patholog
perspect
presenc
inflamm
smooth
muscl
contract
larg
revers
airway
obstruct
inflamm
exagger
airway
respons
associ
mucu
hypersecret
often
increas
eosinophil
local
system
cellular
level
chang
consist
airway
remodel
character
smooth
muscl
hyperplasia
subepitheli
cell
fibrosi
goblet
cell
hyperplasia
neovascular
airway
inflamm
major
compon
asthma
involv
influx
mast
cell
neutrophil
cell
eosinophil
exposur
allergen
infecti
agent
physiolog
chang
occur
driven
inflamm
increas
cytokin
decreas
antiinflammatori
cytokin
ie
heighten
respons
caus
activ
natur
killer
cell
dendrit
cell
eosinophil
result
eosinophilia
increas
matrix
metalloproteas
activ
increas
serum
ige
level
promot
smooth
muscl
hypercontract
central
progress
asthma
produc
respons
tolllik
signal
mani
microrna
directli
indirectli
involv
product
upregul
asthma
may
classifi
two
form
base
histori
skin
test
reactiv
common
inhal
allergen
atop
asthma
case
nonatop
intrins
asthma
nonatop
asthma
usual
late
adult
onset
normal
serum
ige
level
commonli
associ
nasal
polyp
aspirin
sensit
howev
data
suggest
igemedi
mechan
airway
involv
staphylococc
enterotoxin
implic
nonatop
form
asthma
may
commonest
form
children
develop
countri
relat
exposur
environment
dirt
bacteri
infect
psychosoci
distress
poverti
respiratori
virus
account
asthma
exacerb
age
group
rhinovirus
rv
common
caus
common
cold
frequent
culprit
genotyp
c
may
caus
sever
exacerb
respiratori
virus
although
infect
associ
asthma
recurr
wheez
bronchiol
children
admit
hospit
respiratori
tract
infect
clinic
differ
found
genotyp
one
studi
temper
region
infect
rv
respiratori
virus
associ
increas
emerg
room
admiss
asthma
exacerb
asthma
epidem
associ
children
return
school
septemb
anim
model
rv
shown
exacerb
airway
inflamm
induc
airway
allergen
challeng
like
similar
respiratori
virus
well
bacteri
infect
recent
consid
import
pathogenesi
asthma
howev
evid
asthmat
increas
suscept
bacteri
respiratori
infect
children
pneumococc
carriag
common
asthmat
nonasthmat
adult
asthmat
increas
risk
invas
pneumococc
infect
also
increas
evid
mycoplasma
pneumonia
chlamydophila
pneumonia
may
play
role
promot
airway
inflamm
could
contribut
onset
cours
asthma
neonat
colon
hypopharynx
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
increas
risk
recurr
wheez
asthma
earli
life
prospect
studi
europ
also
found
increas
frequenc
c
pneumonia
detect
rtpcr
asthmat
compar
normal
spous
octob
decemb
versu
bronchial
lavag
children
asthma
also
found
slightli
greater
preval
c
pneumonia
pcr
cultur
compar
nonasthmat
variou
respiratori
disord
howev
blood
cultur
posit
c
pneumonia
asthmat
respiratori
disord
versu
match
nonrespiratori
control
significantli
greater
p
role
virus
atyp
bacteria
exacerb
asthma
hospit
children
prospect
evalu
europ
franc
period
hospit
virus
detect
enteroviru
rv
respiratori
syncyti
viru
rsv
atyp
bacteria
persist
clinic
symptom
frequent
associ
atyp
bacteri
infect
similar
prospect
studi
perform
southern
hemispher
argentina
year
two
hundr
nine
patient
assess
potenti
caus
agent
detect
children
frequent
detect
virus
rsv
rv
pneumonia
c
pneumonia
case
respect
impact
acut
respiratori
infect
virus
atyp
bacteria
sever
resolut
symptom
children
nonhospit
exacerb
asthma
also
assess
australia
respiratori
virus
detect
nasopharyng
aspir
differ
clinic
outcom
without
proven
infect
current
overal
data
multipl
studi
indic
virus
much
import
frequent
atyp
bacteria
precipit
exacerb
asthma
good
evid
relat
specif
respiratori
viru
rel
frequenc
variou
respiratori
virus
report
may
vari
accord
age
group
season
geographi
well
method
detect
larg
divers
virus
found
respiratori
tract
adult
without
asthma
use
virochip
dna
microarraybas
detect
method
includ
set
diverg
isol
form
distinct
genet
subgroup
besid
differ
serotyp
rv
multipl
serotyp
human
coronavirus
exact
mechan
upper
respiratori
tract
viral
infect
induc
asthma
attack
fulli
understood
establish
asthma
respiratori
viral
infect
attract
bronchial
inflammatori
cell
alter
airway
receptor
express
smooth
muscl
cell
modul
neuroimmun
mechan
lead
bronchospasm
exacerb
diseas
multipl
mechan
probabl
involv
includ
loss
function
downregul
muscarin
receptor
airway
parasympathet
nerv
normal
inhibit
vagalmedi
bronchospasm
interferon
produc
respons
viral
infect
downregul
express
receptor
gene
eosinophil
recruit
allergen
releas
major
basic
protein
bind
receptor
block
function
thu
multitud
respiratori
virus
caus
upper
lower
respiratori
tract
infect
atyp
bacteria
caus
exacerb
asthma
lower
respiratori
viral
infect
commonli
caus
wheez
young
children
year
age
increas
evid
repeat
viral
bronchiol
earli
life
predispos
asthma
later
childhood
develop
new
onset
asthma
correl
varieti
respiratori
virus
commonli
rsv
bronchiol
infanc
rv
infect
older
children
wheez
ill
infanc
commonli
caus
mark
rsv
bronchiol
episod
less
frequent
parainfluenza
viru
influenza
metapneumovirus
although
rsv
infect
almost
univers
young
children
develop
clinic
overt
diseas
develop
sever
bronchiol
recurr
infect
wheez
risk
factor
sever
lower
respiratori
tract
infect
includ
younger
age
small
lung
size
passiv
smoke
exposur
virusinduc
immun
respons
tucson
children
respiratori
studi
children
follow
birth
decad
develop
lower
respiratori
tract
infect
first
year
life
later
correl
diagnos
asthma
recurr
wheez
age
year
although
rsv
bronchiol
increas
risk
frequent
episod
per
year
infrequ
episod
per
year
wheez
risk
gradual
decreas
age
result
studi
may
explain
recent
studi
assess
recurr
wheez
develop
asthma
birth
cohort
follow
year
relationship
perenni
allergen
exposur
sensit
chronic
asthma
develop
atop
children
first
year
life
repeat
exposur
allergen
determin
continu
allerg
airway
inflamm
character
airwayhyperrespons
impair
lung
function
later
age
school
age
wherea
children
nonatop
wheez
phenotyp
lose
symptom
school
age
retain
normal
pulmonari
function
later
age
studi
suggest
rsv
bronchiol
predispos
recurr
wheez
asthma
genet
predispos
children
larg
epidemiolog
studi
tennesse
usa
found
children
born
approxim
day
peak
rsv
season
highest
risk
hospit
admiss
wheez
higher
risk
later
develop
asthma
howev
associ
sever
rsv
infect
infanc
later
develop
asthma
overlap
genet
determin
studi
twinpair
investig
studi
conclud
sever
rsv
infect
may
caus
asthma
genet
predisposit
rsv
bronchiol
asthma
best
evid
date
support
causal
associ
rsv
infect
asthma
result
longterm
studi
year
swedish
children
children
rsv
bronchiol
infant
compar
match
control
greater
preval
asthma
year
old
versu
affect
children
also
demonstr
increas
perenni
allergen
sensit
versu
recurr
episod
wheez
versu
previou
studi
children
past
bronchiol
enhanc
respons
rsv
cat
allergen
respons
wherea
control
equal
strong
interferongamma
respons
type
rsv
antigen
control
studi
prophylact
therapi
antirsv
monoclon
antibodi
palivizumab
infanc
also
support
causal
role
rsv
asthma
one
studi
treat
untreat
prematur
babi
rate
recurr
wheez
lower
month
treat
babi
investig
later
show
rsv
prophylaxi
treatment
similar
protect
recurr
wheez
older
children
age
year
howev
protect
effect
recurr
wheez
primarili
children
without
famili
histori
asthma
atopi
effect
subsequ
wheez
demonstr
children
famili
histori
asthma
atopi
human
rhinovirus
rv
recogn
common
caus
common
cold
exacerb
asthma
virus
also
caus
lower
respiratori
tract
diseas
lead
hospit
children
without
asthma
increas
evid
rv
infect
lead
develop
asthma
bronchial
epitheli
cell
asthmat
defici
innat
immun
respons
rv
infect
recent
prospect
longitudin
studi
children
high
risk
allerg
diseas
asthma
follow
birth
allerg
sensit
lead
increas
risk
rvinduc
wheez
rsv
infect
year
howev
viral
wheez
lead
subsequ
allerg
sensit
earlier
studi
sensit
common
aeroallergen
nearli
doubl
risk
asthma
year
viral
respiratori
tract
infect
wheez
quadrupl
risk
asthma
time
combin
effect
appear
synergist
risk
asthma
ninefold
greater
wheez
episod
respiratori
infect
allerg
sensit
recent
evid
also
suggest
rv
infect
induc
bronchial
epitheli
product
number
growth
factor
mediat
chemokin
cytokin
could
contribut
develop
progress
airway
remodel
present
asthma
varieti
mechan
propos
explain
increas
suscept
asthmat
certain
respiratori
pathogen
includ
impair
innat
immun
asthma
atop
diseas
includ
defici
epitheli
cell
function
mucu
hypersecret
decreas
interferon
respons
impair
alveolar
macrophag
function
howev
unclear
repeat
viral
bronchiol
earli
childhood
could
lead
asthma
later
year
viral
bronchiti
bronchiol
precipit
acut
attack
wheez
exacerb
asthma
seem
involv
local
inflamm
epitheli
line
enhanc
airway
bronchoconstrict
experiment
induc
viral
infect
anim
human
volunt
indic
virus
enhanc
airway
hyperrespons
virusinduc
airway
hyperrespons
multifactori
involv
chang
neural
control
airway
impair
inactiv
tachykinin
effect
nitric
oxid
product
evid
atop
allerg
subject
increas
ige
eosinophil
airway
inflamm
greater
risk
virusinduc
wheez
nonallerg
individu
although
sever
studi
suggest
interact
respons
viral
infect
aeroallergen
asthma
mechan
unclear
viral
infect
could
damag
epitheli
airway
barrier
enhanc
absorpt
aeroallergen
thu
enhanc
airway
inflamm
gener
variou
cytokin
chemokin
viral
infect
may
upregul
cellular
recruit
enhanc
allergeninduc
inflamm
airway
hyperrespons
experiment
rv
infect
enhanc
lower
airway
histamin
respons
eosinophil
recruit
allergen
challeng
possibl
allerg
inflamm
might
intensifi
host
respons
viral
respiratori
infect
impair
viral
clearanc
suggest
studi
confirm
other
evid
strongest
predictor
subsequ
asthma
presenc
atopi
sever
lower
viral
respiratori
tract
infect
infanc
suggest
interact
least
asthmat
simpli
could
impli
common
predisposit
suscept
asthma
viral
infect
hypothes
sever
recurr
lower
viral
expiratori
infect
hinder
proper
lung
growth
develop
vulner
age
lead
chang
airway
structur
promot
asthma
experiment
evid
rsv
rv
vivo
vitro
increas
synthesi
factor
modul
lung
growth
develop
repair
central
role
pathogenesi
asthma
allergenspecif
ige
product
mediat
cytokin
ige
receptor
mast
cell
basophil
bind
allergen
result
releas
mediat
histamin
produc
airway
inflamm
hyperreact
propos
immun
dysfunct
infanc
could
predispos
recurr
viral
lower
respiratori
tract
infect
involv
pathogenesi
asthma
communitybas
cohort
children
famili
histori
atopi
rel
defici
circul
plasmacytoid
dendrit
cell
infanc
correl
increas
frequenc
sever
viral
respiratori
infect
wheez
diagnos
asthma
usual
respons
viral
respiratori
infect
matur
immun
system
stimul
prolifer
cytolyt
cell
helper
cell
result
releas
upregul
stimul
macrophag
typic
respons
howev
experiment
evid
sever
rsv
infect
neonat
could
determin
pattern
tcellmedi
diseas
later
life
primari
rsv
infect
neonat
mice
associ
reduc
delay
respons
subsequ
reinfect
result
increas
inflammatori
cell
recruit
shift
increas
increas
eosinophil
typic
allergi
asthma
similar
anim
model
also
confirm
viral
respiratori
infect
earli
life
result
overproduct
increas
risk
respiratori
allergi
chang
airway
structur
conduc
asthma
clinic
studi
acut
exacerb
asthma
induc
viral
infect
peripher
blood
mononuclear
cell
demonstr
increas
express
ifnrespons
gene
increas
express
indic
enhanc
allerg
inflamm
link
innat
antivir
respons
crosssect
studi
children
year
age
particip
nation
health
examin
survey
nhane
helicobact
pylori
seroposit
invers
associ
asthma
children
colon
gastrointestin
tract
may
reflect
sanit
exposur
burden
microb
could
support
hygien
hypothesi
investig
previous
report
colon
h
pylori
cag
adult
invers
associ
presenc
asthma
allerg
rhiniti
studi
subject
combin
infecti
burden
h
pylori
toxoplasmosi
gondii
hepat
herp
simplex
c
pneumonia
viru
cytomegaloviru
determin
presenc
antibodi
associ
lower
risk
atopi
asthma
allerg
rhiniti
adult
europ
howev
crosssect
studi
adult
associ
h
pylori
serolog
statu
asthma
atopi
although
experiment
mous
model
allerg
asthma
h
pylori
infect
could
prevent
asthma
develop
induct
regulatori
cell
relationship
intrauterin
bacteri
colon
deliveri
develop
asthma
year
later
children
report
finland
vitro
growth
pathogen
anaerob
bacteria
streptococcu
speci
matern
womb
birth
associ
signific
increas
risk
asthma
diagnosi
compar
neg
bacteri
cultur
sever
limit
studi
howev
includ
small
sampl
size
failur
provid
inform
potenti
risk
factor
household
environ
previou
lower
respiratori
tract
infect
infanc
studi
may
worthwhil
repeat
larger
popul
molecular
method
assess
microbi
environ
vagina
uterin
caviti
household
dust
especi
women
famili
histori
asthma
atop
diseas
oral
microbi
pathogen
influenc
develop
allerg
diseas
topic
review
conclus
biolog
plausibl
oral
bacteria
immun
mechan
could
influenc
risk
allerg
diseas
data
insuffici
draw
conclus
childhood
birth
cohort
prospect
studi
copenhagen
aspir
hypopharynx
obtain
asymptomat
infant
asthmat
mother
bacteri
cultur
subsequ
correl
later
develop
asthma
year
age
colon
hypopharynx
pneumonia
h
influenza
moraxella
catarrhali
combin
organ
increas
risk
recurr
wheez
asthma
earli
life
subsequ
studi
shown
polymorph
gene
associ
childhood
asthma
bacteri
colon
hypopharynx
bronchiol
thu
bacteri
colon
hypopharynx
neonat
childhood
asthma
may
link
genet
predisposit
howev
evid
antibiot
use
earli
life
decreas
increas
risk
later
develop
asthma
postul
bacteri
colon
airway
could
relat
develop
ige
bacteri
antigen
implic
role
bacterialspecif
immun
pathogenesi
asthma
titer
ige
h
influenza
pneumonia
staphylococcu
aureu
measur
teenag
correl
asthma
immunophenotyp
ige
titer
aureusderiv
enterotoxin
highest
among
atop
subject
associ
increas
risk
asthma
howev
high
ige
titer
h
influenza
pneumonia
associ
decreas
risk
asthma
investig
postul
lower
avail
solubl
form
h
influenza
pneumonia
antigen
reduc
crosslink
ige
receptor
system
avail
antigen
mucos
level
antigen
present
cell
memori
cell
could
lead
mucos
secret
produc
atop
respons
aureu
enterotoxin
superantigen
specif
ige
antibodi
associ
asthma
sever
variou
phenotyp
studi
review
metaanalysi
ten
studi
patient
asthma
allerg
rhiniti
like
control
serumspecif
ige
aureu
enterotoxin
recent
casecontrol
studi
aureu
enterotoxin
ige
antibodi
ige
inhal
allergen
grass
pollen
hous
dust
mite
risk
factor
asthma
sever
intestin
microbiota
appear
import
develop
host
innat
immun
may
play
role
pathogenesi
allerg
autoimmun
diseas
recent
studi
investig
relationship
fecal
microbiota
composit
mode
place
deliveri
atop
diseas
fecal
sampl
collect
neonat
age
month
n
determin
microbiota
composit
blood
sampl
collect
age
year
determin
specif
ige
level
colon
clostridium
difficil
month
age
associ
wheez
eczema
throughout
first
year
life
asthma
age
year
vagin
deliveri
home
associ
decreas
risk
eczema
food
allergi
asthma
comparison
vagin
deliveri
hospit
previou
smaller
prospect
birth
cohort
children
found
bacteroid
fragili
fecal
colon
age
week
indic
possibl
asthma
later
life
asthma
predict
index
posit
versu
without
b
fragili
p
anoth
studi
infant
high
risk
atop
diseas
intestin
microbiota
analyz
week
month
age
subsequ
correl
skin
reactiv
month
atop
children
clostridia
fewer
bifidobacteria
reduc
ratio
bifidobacteria
clostridia
nonatop
infant
p
moreov
experiment
studi
mice
shown
alter
gut
microbiota
play
import
role
regul
immun
respons
lung
inhal
antigen
antibioticinduc
perturb
gut
microbiota
produc
allerg
airway
respons
mediat
cell
also
evid
normal
bronchial
tree
steril
contain
mean
bacteri
genom
per
squar
centimet
surfac
area
pathogen
proteobacteria
especi
haemophilu
speci
significantli
increas
asthmat
children
adult
control
convers
bacteroidet
particularli
prevotella
speci
frequent
control
asthmat
remain
unclear
result
crosssect
studi
whether
asthmat
airway
predispos
specif
bacteria
vice
versa
subsequ
studi
adult
suboptim
control
asthma
healthi
control
assess
bacteri
burden
bronchial
epithelium
ribosom
rna
amplicon
concentr
bacteri
divers
concentr
significantli
higher
among
asthmat
patient
control
rel
abund
particular
phenotyp
includ
member
comamonadacea
sphingomonadacea
oxalobacteracea
bacteri
famili
highli
correl
degre
bronchial
hyperrespons
two
studi
suggest
microbiom
airway
may
contribut
pathogenesi
asthma
howev
anoth
recent
studi
use
molecular
method
found
bacteri
commun
lung
indistinguish
upper
airway
microbi
biomass
log
lower
healthi
adult
thu
uniqu
lung
microbiota
microbiom
cellular
molecular
level
mechan
viral
lower
respiratori
tract
infect
asthma
bacteri
colon
airway
environment
exposur
develop
asthma
may
differ
eosinophil
key
effector
cell
atop
asthma
consid
potenti
link
viral
infect
asthma
recruit
eosinophil
airway
main
trigger
inflamm
bronchoconstrict
exposur
aeroallergen
may
play
role
antivir
immun
erad
virus
decreas
invas
epitheli
cell
neutrophil
consid
import
bacteri
infect
part
innat
immun
respons
appear
import
pathogenesi
nonatop
intrins
asthma
estim
asthmat
patient
neutrophil
airway
inflamm
associ
bacteri
persist
h
influenza
airway
steroid
resist
host
factor
like
import
associ
viral
infect
infanc
proceed
develop
asthma
polymorph
gene
control
innat
immun
antivir
immun
respons
associ
asthma
sever
respiratori
tract
infect
earli
childhood
howev
unclear
whether
genet
predisposit
present
fraction
children
develop
asthma
sever
recurr
lower
respiratori
infect
experiment
evid
viral
respiratori
infect
atop
children
may
initi
atopydepend
cascad
amplifi
sustain
airway
inflamm
initi
antivir
immun
util
underli
atopicassoci
mechan
recent
evid
antiig
monthli
prophylact
therapi
significantli
reduc
asthma
exacerb
children
particularli
common
cold
season
support
mechanist
interact
viral
respons
allerg
respons
result
increas
ige
attribut
defect
respons
rhinovirus
atop
asthma
reduc
shift
toward
phenotyp
relationship
commens
microbiota
colon
earli
life
later
develop
asthma
may
partli
explain
recent
experiment
find
previou
investig
demonstr
inflammasom
activ
downstream
cytokin
play
role
innat
adapt
antivir
immun
defens
vivo
recent
studi
mice
demonstr
import
gastrointestin
commens
microbiota
regul
immun
establish
ctl
iga
respons
respiratori
mucosa
follow
influenza
infect
data
indic
commens
microbiota
respons
confer
immunogen
environ
lung
either
gramposit
bacteria
gut
possibl
commens
nasal
mucosa
result
provid
link
commens
microbiota
inflammasomedepend
cytokin
activ
although
hygien
hypothesi
current
vogu
explain
rise
incid
asthma
prosper
countri
theori
recent
postul
chang
diet
differ
develop
countri
develop
nation
associ
chang
gut
microbiota
drive
increas
incid
autoimmun
allerg
diseas
develop
countri
diet
consider
effect
composit
gut
microbiota
experi
mice
show
chang
microbi
composit
metabol
pathway
gene
express
day
western
diet
western
diet
caus
increas
bacteria
firmicut
phylum
decreas
bacteroidet
phylum
gut
microbiota
children
africa
greatli
differ
europ
attribut
primarili
dietari
differ
exampl
provid
author
support
hypothesi
diet
rather
hygien
affect
incid
asthma
rel
low
preval
asthma
japan
compar
australia
unit
state
japan
high
degre
sanit
urban
much
differ
diet
would
influenc
gut
microbiotamicrobiom
addit
urban
poor
usa
greater
frequenc
infect
crowd
like
less
sanitari
habit
still
high
incid
asthma
vitamin
defici
could
common
factor
link
asthma
allergi
respiratori
infect
vitamin
import
effect
function
innat
adapt
immun
vitamin
associ
dosedepend
reduct
transcript
increas
peripher
blood
mononuclear
cell
cultur
thu
vitamin
key
role
balanc
defici
vitamin
common
children
adult
temper
region
world
associ
higher
risk
upper
lower
respiratori
infect
especi
children
vitamin
acquir
ingest
food
synthesi
sunlight
exposur
therefor
higher
preval
vitamin
defici
seen
countri
northern
hemispher
could
explain
greater
incid
asthma
prosper
countri
compar
poorer
nation
predominantli
locat
tropic
subtrop
region
globe
link
vitamin
defici
respiratori
infect
particularli
relev
children
develop
asthma
recurr
respiratori
tract
infect
earli
childhood
season
influenza
rsvinduc
bronchiol
link
greater
preval
vitamin
defici
winter
recent
prospect
birth
cohort
studi
healthi
neonat
low
concentr
vitamin
cord
blood
associ
increas
risk
rsv
bronchiol
first
year
life
sever
epidemiolog
studi
suggest
vitamin
defici
associ
increas
risk
asthma
allerg
diseas
studi
costa
rica
sunlight
exposur
uniform
throughout
year
insuffici
level
vitamin
associ
higher
eosinophil
count
ige
level
increas
airway
hyperrespons
higher
vitamin
level
associ
lower
risk
asthma
exacerb
hospit
result
confirm
anoth
studi
group
investig
cohort
children
suggest
vitamin
may
protect
respiratori
infect
symptom
asthma
reduc
bronchial
inflamm
postul
confirm
small
doubleblind
random
studi
show
vitamin
supplement
reduc
risk
asthma
exacerb
respiratori
tract
infect
fall
spring
howev
studi
found
associ
vitamin
defici
asthma
atopi
fact
report
suggest
vitamin
supplement
increas
risk
asthma
atop
diseas
birth
cohort
studi
finland
found
subject
given
regular
vitamin
supplement
first
year
life
somewhat
higher
risk
asthma
atopi
allerg
rhiniti
adult
compar
control
previous
given
supplement
similarli
swedish
studi
report
high
vitamin
intak
infant
correl
greater
risk
eczema
year
age
concept
commens
microbiota
gut
play
import
role
pathogenesi
asthma
allerg
diseas
suggest
probiot
use
atop
eczema
earliest
manifest
allerg
diseas
children
often
preced
develop
atop
asthma
mice
feed
lactobacillu
casei
strain
shirota
effect
inhibit
ige
product
commonli
use
allergen
valu
probiot
allerg
diseas
assess
sever
random
control
trial
mainli
involv
subject
atop
eczema
allerg
dermat
allerg
rhiniti
main
limit
trial
includ
small
sampl
size
heterogen
lack
standard
accept
probiot
mixtur
topic
last
review
yao
et
al
came
conclus
insuffici
evid
recommend
probiot
allerg
diseas
includ
asthma
author
note
prevent
studi
fail
show
signific
reduct
atop
sensit
report
probiot
administ
perinat
period
associ
greater
risk
later
develop
wheez
asthma
gener
accept
viral
bacteri
respiratori
tract
infect
exacerb
asthma
howev
still
clear
well
establish
microb
caus
asthma
biolog
plausibl
microb
could
play
signific
role
pathogenesi
asthma
accumul
support
evid
past
year
diagrammat
paradigm
role
microb
pathogenesi
asthma
shown
fig
quit
possibl
microb
influenc
develop
asthma
differ
way
depend
underli
genet
predisposit
asthma
truli
heterogen
group
disord
differ
pathogen
mechan
similar
clinic
manifest
studi
elucid
role
microb
causat
asthma
definit
need
combin
variou
aspect
highrisk
birth
cohort
exampl
studi
start
antenat
period
school
age
assess
modern
molecular
method
environment
microbi
composit
ie
hous
dust
microbiota
matern
fece
vagina
uterin
caviti
deliveri
newborn
sampl
upper
airway
hypopharynx
fecal
specimen
test
togeth
plu
document
subsequ
lower
respiratori
tract
infect
year
age
analyz
correl
variou
factor
develop
schoolag
asthma
embark
larg
random
control
trial
earli
childhood
valu
probiot
prevent
asthma
sever
element
met
agreement
among
committe
expert
composit
probiot
chosen
studi
pilot
studi
perform
small
sampl
subject
determin
whether
probiot
supplement
produc
desir
chang
gut
upper
airway
microbiota
composit
endpoint
includ
skin
test
reactiv
aeroallergen
atop
manifest
eczema
develop
wheez
asthma
persist
subsequ
year
school
anoth
prospect
longitudin
studi
highrisk
birth
cohort
warrant
assess
diet
fecal
oropharyng
microbiota
level
vitamin
respiratori
infect
year
later
develop
asthma
larg
sampl
children
